Company patents
Bardy Diagnostics, Inc.
Bardy Diagnostics, Inc. exhibits a highly concentrated patent strategy, with Medical Diagnostics & Surgery patents comprising an overwhelming 97.3% of its portfolio, yet this core area has seen a significant decline in new filings, with a -62.9% YoY drop in 2024 and a -23.1% decline so far in 2026. Surprisingly, despite its medical device focus, the company also holds patents in Material & Chemical Analysis (12.3% of portfolio) and even Routing, Switching & QoS (2.7%), though these appear to be shifting priorities given their volatile or declining yearly trends.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
73 US filings (since 2023) · 5 categories · 5 themes
Development of devices and methods for non-invasive or minimally invasive collection and analysis of physiological data, often from wearable sensors, to monitor health, activity, or specific conditions.
Systems and methods for non-invasive or minimally invasive collection and analysis of physiological data (e.g., blood pressure, electrolytes, genetic markers, B cell repertoire) to assess patient health status, screen for conditions, or aid in diagnosis.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Utilizing machine learning, particularly deep learning, to analyze medical data such as images, sensor readings, or physiological signals for disease prediction, diagnosis, or treatment assessment.
Systems that integrate digital technology, sensors, or connectivity to monitor, track, or automate aspects of medication administration, often providing data feedback, personalized recommendations, or secure logging.
Patents
Showing 1-10 of 122